S&P 500   4,538.43
DOW   34,580.08
QQQ   383.13
S&P 500   4,538.43
DOW   34,580.08
QQQ   383.13
S&P 500   4,538.43
DOW   34,580.08
QQQ   383.13
S&P 500   4,538.43
DOW   34,580.08
QQQ   383.13
OTCMKTS:NSTM

NovelStem International Stock Forecast, Price & News

$0.31
0.00 (0.00%)
(As of 12/3/2021 12:00 AM ET)
Add
Compare
Today's Range
$0.28
$0.31
50-Day Range
$0.21
$0.31
52-Week Range
$0.13
$0.35
Volume
18,097 shs
Average Volume
21,008 shs
Market Capitalization
$13.60 million
P/E Ratio
N/A
Dividend Yield
N/A
Beta
0.13
30 days | 90 days | 365 days | Advanced Chart
Receive NSTM News and Ratings via Email

Sign-up to receive the latest news and ratings for NovelStem International and its competitors with MarketBeat's FREE daily newsletter.


NovelStem International logo

About NovelStem International

NovelStem International Corp. focuses on developing and commercialization of diagnostic technology that can predict patients' resistance to chemotherapy allowing for targeted cancer treatments and the potential to reduce resistance to chemotherapy. It has a collaboration agreement with NewStem Ltd. for stem-cell technology platform in cancer immunotherapy and COVID-19 resistance. The company was formerly known as Hollywood Media Corp. and changed its name to NovelStem International Corp. in September 2018 as a result of its business focus shift from advertising services to stem cell-based diagnostics for cancer chemotherapies. The company was founded in 1993 and is headquartered in Boca Raton, Florida.

Headlines

See More Headlines

Industry, Sector and Symbol

Industry
Retail stores, not elsewhere classified
Sub-Industry
N/A
Sector
Medical
Current Symbol
OTCMKTS:NSTM
CIK
N/A
Phone
N/A
Employees
15
Year Founded
N/A

Sales & Book Value

Annual Sales
N/A

Profitability

Pretax Margin
N/A

Debt

Price-To-Earnings

Miscellaneous

Free Float
37,896,000
Market Cap
$13.60 million
Optionable
Not Optionable

Company Calendar

Today
12/05/2021
Fiscal Year End
12/31/2021

MarketRank

Overall MarketRank

0.17 out of 5 stars

Analyst Opinion: 0.0Community Rank: 0.0Dividend Strength: 0.0Insider Behavior: 0.8Valuation: 0.0 5 -4 -3 -2 -1 -












NovelStem International (OTCMKTS:NSTM) Frequently Asked Questions

Are investors shorting NovelStem International?

NovelStem International saw a increase in short interest during the month of November. As of November 15th, there was short interest totaling 5,100 shares, an increase of 18.6% from the October 31st total of 4,300 shares. Based on an average daily volume of 6,400 shares, the days-to-cover ratio is currently 0.8 days.
View NovelStem International's Short Interest
.

Who are NovelStem International's key executives?

NovelStem International's management team includes the following people:
  • Mr. Mitchell Rubenstein, Co-Founder & Director (Age 67, Pay $665.2k)
  • Mr. David Collins, Investor Relations Firm, Catalyst IR

Who are some of NovelStem International's key competitors?

What is NovelStem International's stock symbol?

NovelStem International trades on the OTCMKTS under the ticker symbol "NSTM."

How do I buy shares of NovelStem International?

Shares of NSTM can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is NovelStem International's stock price today?

One share of NSTM stock can currently be purchased for approximately $0.31.

How much money does NovelStem International make?

NovelStem International has a market capitalization of $13.60 million.

How many employees does NovelStem International have?

NovelStem International employs 15 workers across the globe.

What is NovelStem International's official website?

The official website for NovelStem International is www.novelstem.com.

Where are NovelStem International's headquarters?

NovelStem International is headquartered at 2255 GLADES RD STE 237 W, BOCA RATON FL, 33431.

How can I contact NovelStem International?

NovelStem International's mailing address is 2255 GLADES RD STE 237 W, BOCA RATON FL, 33431. The company can be reached via email at [email protected].


This page was last updated on 12/5/2021 by MarketBeat.com Staff

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.